TGFB1 and neoplasm: Usually, activated cytotoxic T lymphocytes (CTLs) can attack cancer cells to suppress tumor growth, while TAMs express immunosuppressive cytokines, chemokines, and growth factors like IL10 and TGFB1 to make CTLs hyporesponsive (6).